567 related articles for article (PubMed ID: 28752507)
1. Intravenous Alteplase for Acute Ischemic Stroke in Taiwan: Can We Expand the National Health Insurance's Reimbursement Criteria?
Hsieh CY
Acta Neurol Taiwan; 2017 Mar; 26(1):1-2. PubMed ID: 28752507
[TBL] [Abstract][Full Text] [Related]
2. Safety and Effectiveness of Intravenous Thrombolysis for Acute Ischemic Stroke Outside the Coverage of National Health Insurance in Taiwan.
Su YH; Chen CH; Lin HJ; Chen YW; Tseng MC; Hsieh HC; Chen CH; Sung SF
Acta Neurol Taiwan; 2017 Mar; 26(1):3-12. PubMed ID: 28752508
[TBL] [Abstract][Full Text] [Related]
3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
4. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
5. Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.
Cappellari M; Moretto G; Micheletti N; Donato F; Tomelleri G; Gulli G; Carletti M; Squintani GM; Zanoni T; Ottaviani S; Romito S; Tommasi G; Musso AM; Deotto L; Gambina G; Zimatore DS; Bovi P
J Thromb Thrombolysis; 2014 May; 37(4):549-56. PubMed ID: 23943338
[TBL] [Abstract][Full Text] [Related]
6. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
Demaerschalk BM; Kleindorfer DO; Adeoye OM; Demchuk AM; Fugate JE; Grotta JC; Khalessi AA; Levy EI; Palesch YY; Prabhakaran S; Saposnik G; Saver JL; Smith EE;
Stroke; 2016 Feb; 47(2):581-641. PubMed ID: 26696642
[TBL] [Abstract][Full Text] [Related]
7. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
[TBL] [Abstract][Full Text] [Related]
8. Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection.
Ringleb P; Bendszus M; Bluhmki E; Donnan G; Eschenfelder C; Fatar M; Kessler C; Molina C; Leys D; Muddegowda G; Poli S; Schellinger P; Schwab S; Serena J; Toni D; Wahlgren N; Hacke W;
Int J Stroke; 2019 Jul; 14(5):483-490. PubMed ID: 30947642
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Endovascular Thrombectomy with and without Thrombolysis for Acute Large Artery Ischaemic Stroke at a Tertiary Stroke Centre.
Wee CK; McAuliffe W; Phatouros CC; Phillips TJ; Blacker D; Singh TP; Baker E; Hankey GJ
Cerebrovasc Dis Extra; 2017; 7(2):95-102. PubMed ID: 28463832
[TBL] [Abstract][Full Text] [Related]
10. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
[TBL] [Abstract][Full Text] [Related]
11. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
Lorenzano S; Toni D;
Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
[TBL] [Abstract][Full Text] [Related]
13. Intravenous alteplase for stroke: beyond the guidelines and in particular clinical situations.
De Keyser J; Gdovinová Z; Uyttenboogaart M; Vroomen PC; Luijckx GJ
Stroke; 2007 Sep; 38(9):2612-8. PubMed ID: 17656661
[TBL] [Abstract][Full Text] [Related]
14. Code stroke: a mismatch between number of activation and number of thrombolysis.
Sung SF; Tseng MC
J Formos Med Assoc; 2014 Jul; 113(7):442-6. PubMed ID: 24961186
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
[TBL] [Abstract][Full Text] [Related]
16. How Do Physicians Approach Intravenous Alteplase Treatment in Patients with Acute Ischemic Stroke Who Are Eligible for Intravenous Alteplase and Endovascular Therapy? Insights from UNMASK-EVT.
Ospel JM; Kashani N; Fischer U; Menon BK; Almekhlafi M; Wilson AT; Foss MM; Saposnik G; Goyal M; Hill MD
AJNR Am J Neuroradiol; 2020 Feb; 41(2):262-267. PubMed ID: 31974081
[TBL] [Abstract][Full Text] [Related]
17. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
18. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
[TBL] [Abstract][Full Text] [Related]
19. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2 × 2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment.
Huang Y; Sharma VK; Robinson T; Lindley RI; Chen X; Kim JS; Lavados P; Olavarría V; Arima H; Fuentes S; Nguyen HT; Lee TH; Parsons MW; Levi C; Demchuk AM; Bath PM; Broderick JP; Donnan GA; Martins S; Pontes-Neto OM; Silva F; Pandian J; Ricci S; Stapf C; Woodward M; Wang J; Chalmers J; Anderson CS;
Int J Stroke; 2015 Jul; 10(5):778-88. PubMed ID: 25832995
[TBL] [Abstract][Full Text] [Related]
20. Alteplase and ischaemic stroke: have new reviews of old data helped?
Lindley RI; Wardlaw JM; Sandercock PA
Lancet Neurol; 2005 Apr; 4(4):249-53. PubMed ID: 15778104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
